Lenz Therapeutics Inc Asset Turnover Ratio (LENZ), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Lenz Therapeutics Inc   (NASDAQ: LENZ)
 

Lenz Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Lenz Therapeutics Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.08 in the first quarter (Mar 31 2026)

Within sector 46 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from 0 to 2633.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LENZ Asset Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change 35.42 % 42.07 % -5.94 % 7.85 % -7.15 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.08 0.08 0.08 0.02 -
LENZ's Total Ranking # 2633 # 0 # 0 # 0 # 0
Seq. Asset Change -10.9 % 45.17 % -3.05 % 7.99 % -6.53 %
Seq. Revenue Change 19.71 % -87.3 % 150 % - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 47
Healthcare Sector # 445
Overall Market # 2633

Asset Turnover Ratio Statistics
High Average Low
0.08 0.08 0.08
(Mar 31 2026)  




LENZ Company Profile • Back to LENZ Efficiency Comparisons • Compare LENZ Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Editas Medicine Inc   0.21 $ 38.693  Millions$ 187.051  Millions
Wave Life Sciences Ltd   0.21 $ 88.173  Millions$ 428.944  Millions
Pacific Biosciences Of California Inc   0.20 $ 159.992  Millions$ 798.769  Millions
Zymeworks Inc   0.20 $ 81.263  Millions$ 407.599  Millions
Ligand Pharmaceuticals Incorporated  0.20 $ 274.476  Millions$ 1,379.530  Millions
Arcturus Therapeutics Holdings Inc   0.20 $ 54.710  Millions$ 277.043  Millions
Dariohealth Corp   0.19 $ 20.983  Millions$ 109.852  Millions
Xoma Royalty Corporation  0.19 $ 48.555  Millions$ 257.791  Millions
Coya Therapeutics Inc   0.19 $ 7.939  Millions$ 42.179  Millions
Biocorrx Inc   0.19 $ 0.877  Millions$ 4.672  Millions
Moderna Inc   0.19 $ 2,225.000  Millions$ 11,992.750  Millions
Beyond Air Inc   0.18 $ 6.065  Millions$ 32.810  Millions
Regenxbio Inc   0.18 $ 87.822  Millions$ 475.289  Millions
Cannapharmarx Inc   0.18 $ 1.654  Millions$ 9.172  Millions
Alpha Cognition Inc.  0.18 $ 10.825  Millions$ 60.101  Millions
4d Molecular Therapeutics Inc   0.18 $ 88.242  Millions$ 494.309  Millions
60 Degrees Pharmaceuticals Inc   0.17 $ 1.004  Millions$ 5.750  Millions
Inspiremd Inc   0.17 $ 10.044  Millions$ 59.422  Millions
Cytomx Therapeutics Inc   0.17 $ 35.542  Millions$ 211.059  Millions
Prothena Corporation Public Limited Company  0.16 $ 57.940  Millions$ 357.098  Millions
Maxcyte inc   0.16 $ 32.287  Millions$ 207.552  Millions
Skinvisible Inc   0.15 $ 0.020  Millions$ 0.131  Millions
China Pharma Holdings Inc  0.15 $ 3.992  Millions$ 26.429  Millions
Autolus Therapeutics Plc  0.15 $ 92.624  Millions$ 624.765  Millions
Standard Biotools Inc   0.15 $ 85.215  Millions$ 575.867  Millions
Lineage Cell Therapeutics Inc   0.15 $ 14.779  Millions$ 100.639  Millions
Nektar Therapeutics  0.14 $ 55.633  Millions$ 388.140  Millions
Femasys Inc   0.14 $ 2.377  Millions$ 16.823  Millions
Safe Pro Group Inc   0.13 $ 1.642  Millions$ 12.272  Millions
Scilex Holding Company  0.13 $ 33.862  Millions$ 254.563  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.